MO SB 861
died on adjournmentModifies provisions relating to gender transition
Missouri · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did MO SB 861 pass?
No. MO SB 861 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-12-01): Prefiled
What is MO SB 861 about?
SB 861 - Under this act, and unless clearly and specifically stated otherwise, the term "reproductive health care", as used in the laws and regulations of this state, shall not be construed to include gender transition surgeries or the use of cross-sex hormones or puberty-blocking drugs for the purpose of gender transition for minor children or adults. This provision is identical to SB 26 (2025), SB 1459 (2024), and HB 2830 (2024). Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date. This provision is identical to provisions in SB 26 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 249 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024), substantially similar to SB 75 (2025), and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024). SARAH HASKINS
Who sponsors MO SB 861?
Moon, Mike is the primary sponsor of MO SB 861.
Description
SB 861 - Under this act, and unless clearly and specifically stated otherwise, the term "reproductive health care", as used in the laws and regulations of this state, shall not be construed to include gender transition surgeries or the use of cross-sex hormones or puberty-blocking drugs for the purpose of gender transition for minor children or adults. This provision is identical to SB 26 (2025), SB 1459 (2024), and HB 2830 (2024). Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date. This provision is identical to provisions in SB 26 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 249 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024), substantially similar to SB 75 (2025), and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024). SARAH HASKINS
- Introduced
- —
- Latest action
- 2025-12-01 — Prefiled
- Bill type
- bill
- Last updated
- —
Sponsors
- Moon, Mikeprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-04-08
Voted Do Pass S Families, Seniors and Health Committee
committee-passage
2026-01-28
Hearing Conducted S Families, Seniors and Health Committee
2026-01-08
Second Read and Referred S Families, Seniors and Health Committee
reading-2,referral-committee
2026-01-07
S First Read
reading-1
2025-12-01
Prefiled
Versions
- 5129S.01I - IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-08-21T21:08:48.597527Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MO&identifier=SB 861. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.